{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:45:55Z","timestamp":1791420355812,"version":"4.3.3"},"reference-count":17,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Alzheimer\u2019s Disease (AD) and Mild Cognitive Impairment (MCI) are debilitating diseases that affect millions of individuals and have notoriously limited treatment options. One emerging therapy, non-invasive 40 Hz sensory therapy delivered through light and sound has previously shown promise in improving cognition in Alzheimer Disease (AD) rodent models. Small studies in humans have proven safe and tolerable, however exploration of feasibility and utility is limited. The purpose of this study is to examine the feasibility of this treatment in a human population through a smart tablet application that emits light and sound waves at 40 Hz to the user over the span of 1 h a day. Confirmation of entrainment of 40 Hz stimulation in the cerebral cortex was performed via EEG. 27 preliminary subjects with subjective cognitive complaints, Mild Cognitive Impairment, or AD were enrolled in the study; 11 participants completed 6 months of therapy. Of those that discontinued treatment, other health issues and difficulties with compliance were the most common causes. Participants were followed with Montreal Cognitive Assessment (MOCA) and Boston Cognitive Assessment (BOCA). For participants with subjective cognitive complaints, 2 of the 4 had improved MOCA score and 1 of 4 had improved BOCA score. For the participant with MCI, his MOCA score improved. For AD participants, 2 out of 6 had improved MOCA score and 3 of the 6 stayed stable, while 3 of 6 BOCA score improved. 4 of 11 participants specifically increased their MOCA scores in the Memory Index section. Of the 8 participants\/caregivers able to speak to perceived usefulness of the study, 6 spoke to at least some level of benefit. Of these 6, 2 enrolled with subjective cognitive complaint, 1 had MCI, and 3 had AD. The therapy did not have reported side effects. However, those who did not finish the study experienced issues obtaining and operating a smart tablet independently as well as complying with the therapy. Overall, further exploration of this treatment modalities efficacy is warranted.<\/jats:p>","DOI":"10.3390\/healthcare11142040","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:41:05Z","timestamp":1689554465000},"page":"2040","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Feasibility Study of AlzLife 40 Hz Sensory Therapy in Patients with MCI and Early AD"],"prefix":"10.3390","volume":"11","author":[{"given":"Sienna D.","family":"McNett","sequence":"first","affiliation":[{"name":"Center for Integrative Medicine, George Washington University, Washington, DC 20052, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1610-8716","authenticated-orcid":false,"given":"Andrey","family":"Vyshedskiy","sequence":"additional","affiliation":[{"name":"MET, Boston University, Boston, MA 02215, USA"},{"name":"Alzheimer\u2019s Light, Miami, FL 33626, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Savchenko","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Light, Miami, FL 33626, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijel","family":"Durakovic","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Light, Miami, FL 33626, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Heredia","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Southern California, Los Angeles, CA 90007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rael","family":"Cahn","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Southern California, Los Angeles, CA 90007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Kogan","sequence":"additional","affiliation":[{"name":"Center for Integrative Medicine, George Washington University, Washington, DC 20052, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Feigin","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/WAD.0000000000000262","article-title":"Relationships between Cognitive Complaints and Quality of Life in Older Adults with Mild Cognitive Impairment, Mild Alzheimer\u2019s Disease Dementia, and Normal Cognition","volume":"32","author":"Stites","year":"2018","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer\u2019s disease drug-development pipeline: Few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature17172","article-title":"Memory retrieval by activating engram cells in mouse models of early Alzheimer\u2019s disease","volume":"531","author":"Roy","year":"2016","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature20587","article-title":"Gamma frequency entrainment attenuates amyloid load and modifies microglia","volume":"540","author":"Iaccarino","year":"2016","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cell.2019.02.014","article-title":"Multi-sensory gamma stimulation ameliorates Alzheimer\u2019s-associated pathology and improves cognition","volume":"177","author":"Martorell","year":"2019","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e12178","DOI":"10.1002\/trc2.12178","article-title":"A feasibility trial of gamma sensory flicker for patients with prodromal Alzheimer\u2019s disease","volume":"7","author":"He","year":"2021","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chan, D., Suk, H.-J., Jackson, B.L., Milman, N.P., Stark, D., Klerman, E.B., Kitchener, E., Fernandez Avalos, V.S., de Weck, G., and Banerjee, A. (2022). Gamma frequency sensory stimulation in mild probable Alzheimer\u2019s dementia patients: Results of feasibility and pilot studies. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0278412"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.conb.2018.07.009","article-title":"Gamma oscillations in cognitive disorders","volume":"52","author":"Mably","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature08573","article-title":"Frequency of gamma oscillations routes flow of information in the hippocampus","volume":"462","author":"Colgin","year":"2009","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"117996","DOI":"10.1016\/j.lfs.2020.117996","article-title":"Alzheimer\u2019s disease; a review of the pathophysiological basis and therapeutic interventions","volume":"256","author":"Abeysinghe","year":"2020","journal-title":"Life Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"108352","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1212\/WNL.0000000000012453","article-title":"Clinical efficacy, drug safety, and surrogate endpoints: Has aducanumab met all of its expectations?","volume":"97","author":"Hershey","year":"2021","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S1041610211001839","article-title":"Screening utility of the Montreal Cognitive Assessment (MoCA): In place of\u2014Or as well as\u2014The MMSE?","volume":"24","author":"Larner","year":"2012","journal-title":"Int. Psychogeriatr."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Vyshedskiy, A., Netson, R., Fridberg, E., Jagadeesan, P., Arnold, M., Barnett, S., Gondalia, A., Maslova, V., de Torres, L., and Ostrovsky, S. (2022). Boston cognitive assessment (BOCA)\u2014A comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performance. BMC Neurol., 22.","DOI":"10.1186\/s12883-022-02620-6"}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/14\/2040\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:13:05Z","timestamp":1760127185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/14\/2040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":17,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["healthcare11142040"],"URL":"https:\/\/doi.org\/10.3390\/healthcare11142040","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]}}}